Patients losing more than 20% of their body weight experience higher rates of hair shedding than those with more gradual loss
10.1212/wnl.25.7.603 24 CarricoC.MeyerJ
As we have seen, semaglutide, a GLP-1 receptor agonist known for its efficacy in managing type 2 diabetes and obesity, may also impact hormonal balance, particularly in patients undergoing hormone replacement therapy (HRT)
7 SURPASS-5 (NCT04039503) was a 40-week study comparing the efficacy and safety of Mounjaro 5 mg (N=116), 10 mg (N=118) and 15 mg (N=118) to placebo (N=119) in adults with inadequately controlled type 2 diabetes already being treated with insulin glargine, with or without metformin
10.3389/fnmol.2017.00167 117 FrakesA
Stop and Seek Help If Any severe hypoglycemic episode that doesn't resolve quickly with food Persistent numbness, tingling, or carpal tunnel symptoms Joint pain that interferes with training or daily activities Signs of allergic reaction (rash, swelling, difficulty breathing) Any concerning or unusual symptoms that worry you Completion of your planned cycle (typically 4-6 weeks) IGF-1 LR3 is a research compound, not approved for human therapeutic use by the FDA